» Authors » Oliver Drognitz

Oliver Drognitz

Explore the profile of Oliver Drognitz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 729
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zschiedrich S, Janigen B, Dimova D, Neumann A, Seidl M, Hils S, et al.
Nephrol Dial Transplant . 2015 Nov; 31(4):663-71. PMID: 26610596
Background: ABO-incompatible kidney transplantation (ABOi KTx) expands the living donor transplantation options. However, long-term outcome data, especially in comparison with ABO-compatible kidney transplantation (ABOc KTx), remain limited. Since the first...
2.
Tittelbach-Helmrich D, Thurow C, Arwinski S, Schleicher C, Hopt U, Bausch D, et al.
Transpl Int . 2014 Oct; 28(2):191-8. PMID: 25345374
Kidney transplantation is limited not by technical or immunological challenges but by lack of donor organs. Whereas the number of patients on waiting list increased, the transplantation rate decreased. We...
3.
Tittelbach-Helmrich D, Bausch D, Drognitz O, Goebel H, Schulz-Huotari C, Kramer-Zucker A, et al.
Case Rep Med . 2014 Oct; 2014:613641. PMID: 25317177
We present a case report of a 59-year-old man, who received a blood group identical living unrelated kidney graft. This was his second kidney transplantation. Pretransplant T-cell crossmatch resulted negative....
4.
Tittelbach-Helmrich D, Pisarski P, Offermann G, Geyer M, Thomusch O, Hopt U, et al.
World J Transplant . 2014 Jul; 4(2):141-7. PMID: 25032103
Aim: To determine the impact of transplant nephrectomy on peak panel reactive antibody (PRA) levels, patient and graft survival in kidney re-transplants. Methods: From 1969 to 2006, a total of...
5.
Neeff H, Streule G, Drognitz O, Tittelbach-Helmrich D, Spangenberg H, Hopt U, et al.
Surgery . 2014 Jan; 155(4):623-32. PMID: 24468037
Background: Patients with liver cirrhosis have an increased risk of postoperative mortality. In addition, cirrhotic patients per se have a reduced life expectancy. Little is known about the combined effect...
6.
Flecken T, Schmidt N, Hild S, Gostick E, Drognitz O, Zeiser R, et al.
Hepatology . 2013 Sep; 59(4):1415-26. PMID: 24002931
Unlabelled: Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide with a poor prognosis and limited therapeutic options. To aid the development of novel immunological interventions, we studied the...
7.
Lamy E, Hertrampf A, Herz C, Schuler J, Erlacher M, Bertele D, et al.
PLoS One . 2013 Aug; 8(8):e70846. PMID: 23936472
Isothiocyanates from plants of the order Brassicales are considered promising cancer chemotherapeutic phytochemicals. However, their selective cytotoxicity on liver cancer has been barely researched. Therefore, in the present study, we...
8.
Jilg C, Drendel V, Bacher J, Pisarski P, Neeff H, Drognitz O, et al.
Nephron Clin Pract . 2013 Jun; 123(1-2):13-21. PMID: 23752029
Background: The role of autosomal dominant polycystic kidney disease (ADPKD) as a risk factor for renal cell carcinoma (RCC) is still under discussion. Data on prevalence of RCC in ADPKD...
9.
Neeff H, Drognitz O, Holzner P, Klock A, Bronsert P, Hopt U, et al.
Int J Colorectal Dis . 2013 Mar; 28(8):1135-41. PMID: 23468250
Introduction: Although advances in multimodal treatment have led to prolongation of survival in patients after resection of colorectal liver metastasis (CRC-LM), most patients develop recurrence, which is often confined to...
10.
Neeff H, Pisarski P, Tittelbach-Helmrich D, Karajanev K, Neumann H, Hopt U, et al.
Nephrol Dial Transplant . 2012 Oct; 28(2):466-71. PMID: 23042709
Purpose: Surgical management of autosomal dominant polycystic kidney disease (ADPKD) in patients awaiting renal transplantation is a challenging task. Methods: From 1998 to 2009, a total of 100 consecutive renal...